Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

BACKGROUND: Cancer and its therapies increase the risk of venous thromboembolism. Compared to patients without cancer, patients with cancer anticoagulated for venous thromboembolism are more likely to develop recurrent thrombotic events and major bleeding. Addressing all important outcomes including...

Descripción completa

Detalles Bibliográficos
Autores principales: Akl, Elie A, Barba, Maddalena, Rohilla, Sandeep, Terrenato, Irene, Sperati, Francesca, Muti, Paola, Schünemann, Holger J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2507703/
https://www.ncbi.nlm.nih.gov/pubmed/18634550
http://dx.doi.org/10.1186/1756-9966-27-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2507703/
https://www.ncbi.nlm.nih.gov/pubmed/18634550
http://dx.doi.org/10.1186/1756-9966-27-21

Ejemplares similares